Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population

  1. Nightingale Health UK Biobank Initiative
  2. Heli Julkunen
  3. Anna Cichońska
  4. P Eline Slagboom
  5. Peter Würtz  Is a corresponding author
  1. Nightingale Health Ltd, Finland
  2. Leiden University Medical Center, Netherlands

Abstract

Biomarkers of low-grade inflammation have been associated with susceptibility to a severe infectious disease course, even when measured prior to disease onset. We investigated whether metabolic biomarkers measured by nuclear magnetic resonance (NMR) spectroscopy could be associated with susceptibility to severe pneumonia (2507 hospitalised or fatal cases) and severe COVID-19 (652 hospitalised cases) in 105,146 generally healthy individuals from UK Biobank, with blood samples collected 2007–2010. The overall signature of metabolic biomarker associations was similar for the risk of severe pneumonia and severe COVID-19. A multi-biomarker score, comprised of 25 proteins, fatty acids, amino acids and lipids, was associated equally strongly with enhanced susceptibility to severe COVID-19 (odds ratio 2.9 [95%CI 2.1–3.8] for highest vs lowest quintile) and severe pneumonia events occurring 7–11 years after blood sampling (2.6 [1.7–3.9]). However, the risk for severe pneumonia occurring during the first 2 years after blood sampling for people with elevated levels of the multi-biomarker score was over four times higher than for long-term risk (8.0 [4.1–15.6]). If these hypothesis generating findings on increased susceptibility to severe pneumonia during the first few years after blood sampling extend to severe COVID-19, metabolic biomarker profiling could potentially complement existing tools for identifying individuals at high risk. These results provide novel molecular understanding on how metabolic biomarkers reflect the susceptibility to severe COVID-19 and other infections in the general population.

Data availability

The data are available for approved researchers from UK Biobank. The metabolic biomarker data has been released to the UK Biobank resource in March 2021.

The following previously published data sets were used
    1. Sudlow et al
    (2015) UK Biobank
    https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001779.

Article and author information

Author details

  1. Nightingale Health UK Biobank Initiative

  2. Heli Julkunen

    R&D, Nightingale Health Ltd, Helsinki, Finland
    Competing interests
    Heli Julkunen, HJ is employee of Nightingale Health Ltd..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4282-0248
  3. Anna Cichońska

    R&D, Nightingale Health Ltd, Helsinki, Finland
    Competing interests
    Anna Cichońska, AC is employee and hold stock options with Nightingale Health Ltd..
  4. P Eline Slagboom

    Leiden University Medical Center, Leiden, Netherlands
    Competing interests
    No competing interests declared.
  5. Peter Würtz

    R&D, Nightingale Health Ltd, Helsinki, Finland
    For correspondence
    peter.wurtz@nightingalehealth.com
    Competing interests
    Peter Würtz, PW is employee and shareholder of Nightingale Health Ltd..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5832-0221

Funding

The study was funded by Nightingale Health Plc. Three of the study authors are employees of Nightingale Health Plc.

Reviewing Editor

  1. Edward D Janus, University of Melbourne, Australia

Ethics

Human subjects: The UK Biobank recruited 502 639 participants aged 37-70 years in 22 assessment centres across the UK. All participants provided written informed consent and ethical approval was obtained from the North West Multi-Center Research Ethics Committee. Details of the design of the UK Biobank have been reported previously (Sudlow et al PLOS Medicine 2015). The current analysis was approved under UK Biobank Project 30418.

Version history

  1. Received: September 11, 2020
  2. Accepted: May 2, 2021
  3. Accepted Manuscript published: May 4, 2021 (version 1)
  4. Version of Record published: June 2, 2021 (version 2)

Copyright

© 2021, Julkunen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,917
    views
  • 463
    downloads
  • 116
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nightingale Health UK Biobank Initiative
  2. Heli Julkunen
  3. Anna Cichońska
  4. P Eline Slagboom
  5. Peter Würtz
(2021)
Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population
eLife 10:e63033.
https://doi.org/10.7554/eLife.63033

Share this article

https://doi.org/10.7554/eLife.63033

Further reading

    1. Epidemiology and Global Health
    Xiaoxin Yu, Roger S Zoh ... David B Allison
    Review Article

    We discuss 12 misperceptions, misstatements, or mistakes concerning the use of covariates in observational or nonrandomized research. Additionally, we offer advice to help investigators, editors, reviewers, and readers make more informed decisions about conducting and interpreting research where the influence of covariates may be at issue. We primarily address misperceptions in the context of statistical management of the covariates through various forms of modeling, although we also emphasize design and model or variable selection. Other approaches to addressing the effects of covariates, including matching, have logical extensions from what we discuss here but are not dwelled upon heavily. The misperceptions, misstatements, or mistakes we discuss include accurate representation of covariates, effects of measurement error, overreliance on covariate categorization, underestimation of power loss when controlling for covariates, misinterpretation of significance in statistical models, and misconceptions about confounding variables, selecting on a collider, and p value interpretations in covariate-inclusive analyses. This condensed overview serves to correct common errors and improve research quality in general and in nutrition research specifically.

    1. Ecology
    2. Epidemiology and Global Health
    Emilia Johnson, Reuben Sunil Kumar Sharma ... Kimberly Fornace
    Research Article

    Zoonotic disease dynamics in wildlife hosts are rarely quantified at macroecological scales due to the lack of systematic surveys. Non-human primates (NHPs) host Plasmodium knowlesi, a zoonotic malaria of public health concern and the main barrier to malaria elimination in Southeast Asia. Understanding of regional P. knowlesi infection dynamics in wildlife is limited. Here, we systematically assemble reports of NHP P. knowlesi and investigate geographic determinants of prevalence in reservoir species. Meta-analysis of 6322 NHPs from 148 sites reveals that prevalence is heterogeneous across Southeast Asia, with low overall prevalence and high estimates for Malaysian Borneo. We find that regions exhibiting higher prevalence in NHPs overlap with human infection hotspots. In wildlife and humans, parasite transmission is linked to land conversion and fragmentation. By assembling remote sensing data and fitting statistical models to prevalence at multiple spatial scales, we identify novel relationships between P. knowlesi in NHPs and forest fragmentation. This suggests that higher prevalence may be contingent on habitat complexity, which would begin to explain observed geographic variation in parasite burden. These findings address critical gaps in understanding regional P. knowlesi epidemiology and indicate that prevalence in simian reservoirs may be a key spatial driver of human spillover risk.